<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biobank Introduction</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            line-height: 1.6;
            margin: 0;
            padding: 0;
            background-color: #f4f4f4;
        }
        .header {
            text-align: center;
            color: #fff;
            background: linear-gradient(90deg, #2C3E50, #4A4A4A);
            padding: 20px;
            border-bottom: 5px solid #1A242F;
        }
        .header h1 {
            margin: 0;
            padding: 0;
            font-size: 2.5em;
        }
        .intro {
            text-align: left;
            color: #fff;
            padding: 10px;
            margin: 0;
            font-size: 1.25em;
        }
        .biobank {
            border: 1px solid #ccc;
            border-radius: 5px;
            padding: 20px;
            margin-bottom: 20px;
            margin: 20px auto;
            background-color: #f9f9f9;
            max-width: 1300px;
            box-shadow: 0 2px 5px rgba(0, 0, 0, 0.1);
        }
        .biobank h2 {
            margin-top: 0;
        }
        .biobank a {
            color: #007BFF;
            text-decoration: none;
        }
        .biobank a:hover {
            text-decoration: underline;
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>The Large-scale Biobanks</h1>
        <div class="intro">
            <p>Discover the leading biobanks that provide invaluable data resources for medical research and disease treatment. Explore their contributions and find out how they are driving advancements in healthcare.</p>
        </div>
    </div>
    <div class="biobank">
        <h2>1. UK Biobank</h2>
        <p><strong>Introduction:</strong><br>UK Biobank is a large-scale, long-term biomedical database containing detailed health and genetic information from approximately 500,000 UK volunteers. The data spans genomics, imaging, health records, and lifestyle factors.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> 500,000</li>
            <li><strong>Data Types:</strong> Genomic data, imaging data, health records, lifestyle questionnaires, etc.</li>
            <li><strong>Research Areas:</strong> Broad medical and health research, including cardiovascular disease, cancer, diabetes, etc.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.ukbiobank.ac.uk/" target="_blank">UK Biobank</a></p>
        <p><strong>Publication:</strong> <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60404-8/abstract" target="_blank">What makes UK Biobank special?</a></p>
    </div>
    
    <div class="biobank">
        <h2>2. All of Us Research Program</h2>
        <p><strong>Introduction:</strong><br>The All of Us Research Program, initiated by the National Institutes of Health (NIH), strives to transform health care by creating a comprehensive database that reflects the rich diversity of the United States. By collecting detailed health information from at least one million people, the program aims to speed up medical breakthroughs and reduce health disparities. This initiative supports the development of precision medicine by integrating diverse data sources such as genomic, electronic health records, and lifestyle information. </p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> Over 545,000 individuals enrolled, aiming for a target of 1 million or more</li>
            <li><strong>Data Types:</strong> Genomic data, electronic health records, environmental data, lifestyle questionnaires, etc.</li>
            <li><strong>Research Areas:</strong> Precision medicine, health disparities, chronic diseases, etc.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://allofus.nih.gov/" target="_blank">All of Us Research Program</a></p>
    </div>
    
    
    <div class="biobank">
        <h2>3. FinnGen</h2>
        <p><strong>Introduction:</strong><br>FinnGen is a public–private partnership research project that combines imputed genotype data generated from newly collected and legacy samples from Finnish biobanks and digital health record data from Finnish health registries (https://www.finngen.fi/en) with the aim to provide new insights into disease genetics. FinnGen includes 9 Finnish biobanks, research institutes, universities and university hospitals, 13 international pharmaceutical industry partners and the Finnish Biobank Cooperative (FINBB) in a pre-competitive partnership.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> 500,000 participants.</li>
            <li><strong>Data Types:</strong> Imputed genotype data from newly collected and legacy samples, digital health record data from Finnish health registries collected since 1969.</li>
            <li><strong>Research Areas:</strong> Disease genetics, identification of low-frequency deleterious alleles, genetic basis of health and disease, Finnish Disease Heritage.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.finngen.fi/en" target="_blank">FinnGen</a></p>
        <p><strong>Publication:</strong> <a href="https://www.nature.com/articles/s41586-022-05473-8" target="_blank">FinnGen provides genetic insights from a well-phenotyped isolated population</a></p>
    </div>
    
    <div class="biobank">
        <h2>4. The Cancer Genome Atlas (TCGA)</h2>
        <p><strong>Introduction:</strong><br>TCGA is a project by the National Institutes of Health in the United States, aiming to perform genomic analyses of various cancers to advance cancer research and treatment. TCGA collected, characterized, and analyzed cancer samples from over 11,000 patients over a 12 year period. The process was complex and constantly evolving to accommodate new technologies, the nuances of different cancer types, and other changing factors.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> Over 11,000 patients.</li>
            <li><strong>Data Types:</strong> clinical information (e.g., smoking status), molecular analyte metadata (e.g., sample portion weight), molecular characterization data (e.g., gene expression values)</li>
            <li><strong>Research Areas:</strong> Cancer genomics, cancer treatment, molecular markers</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga" target="_blank">The Cancer Genome Atlas (TCGA)</a></p>
    </div>
    <div class="biobank">
        <h2>5. Million Veteran Program</h2>
        <p><strong>Introduction:</strong><br>The Million Veteran Program (MVP) is a health research initiative studying the impact of genes, lifestyles, military experiences, and exposures on health. MVP makes significant discoveries for Veterans, including better prevention and treatment for PTSD, depression, anxiety, and suicide. It also examines risk and protective factors for heart diseases and advances cancer research, focusing on breast and prostate cancers. The program promotes healthier living through nutrition and lifestyle choices and investigates various conditions such as diabetes, Alzheimer’s disease, endometriosis, osteoarthritis, and impacts of military exposures, driving medical advancements relevant to Veterans.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> As of August 3, 2015, the Million Veteran Program (MVP) has enrolled 397,104 veterans across about 50 nationwide sites, with genotyping data available for 199,348 participants.</li>
            <li><strong>Data Types:</strong> Questionnaires, VA electronic health records, blood samples for genomic and other testing</li>
            <li><strong>Research Areas:</strong> Precision medicine, genomic research, health care delivery, clinical decision-making</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.mvp.va.gov/pwa/" target="_blank">Million Veteran Program</a></p>
        <p><strong>Publication:</strong> <a href="https://www.jclinepi.com/article/S0895-4356(15)00444-8/fulltext" target="_blank">Million Veteran Program: A mega-biobank to study genetic influences on health and disease</a></p>
    </div>
    <div class="biobank">
        <h2>6. BioBank Japan</h2>
        <p><strong>Introduction:</strong><br>Established in 2003 at the University of Tokyo, BioBank Japan (BBJ) is a national project aimed at realizing personalized medicine through genetic information. BBJ collects and securely stores biological samples and clinical data, removing personal details like name, address, and date of birth, and assigning new ID numbers for research. These samples and data are provided to researchers in academic institutions and private companies to advance genomic medicine and develop new diagnostic and therapeutic methods. BBJ supports the development of personalized medicine by facilitating research based on genetic information.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> 270,000 patients</li>
            <li><strong>Data Types:</strong> DNA from all participants at baseline, annual serum samples, clinical information via interviews and medical record reviews</li>
            <li><strong>Research Areas:</strong> Personalized medicine, genomic research, survival data analysis</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://biobankjp.org/" target="_blank">BioBank Japan</a></p>
        <p><strong>Publication:</strong> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350590/" target="_blank">Overview of the BioBank Japan Project: Study design and profile</a></p>
    </div>
    <div class="biobank">
        <h2>7. BioVU</h2>
        <p><strong>Introduction:</strong><br>BioVU is Vanderbilt University Medical Center’s biobank that has achieved a significant milestone — the deep-freeze storage of more than 300,000 biological samples. Launched in 2007, BioVU is the world’s largest DNA biobank based at a single academic institution. The project aims to develop a DNA biobank linked to phenotypic data derived from electronic medical records (EMR) to facilitate a wide range of biomedical research, particularly studies of genotype-phenotype associations.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> Over 300,000 de-identified DNA samples linked to electronic health records as of January 2023.</li>
            <li><strong>Data Types:</strong> Genomic data, electronic health records, biospecimens.</li>
            <li><strong>Research Areas:</strong> Personalized medicine, genetic determinants of disease, pharmacogenomics, disease mechanisms.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://victr.vumc.org/biovu-description/" target="_blank">BioVU</a></p>
        <p><strong>Publication:</strong> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763939/" target="_blank">Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine</a></p>
    </div>
    <div class="biobank">
        <h2>8. Mayo Clinic Biobank</h2>
        <p><strong>Introduction:</strong><br>The Mayo Clinic Biobank is a comprehensive biorepository created to support a wide range of medical research. Launched in 2009, it is part of Mayo Clinic's extensive commitment to individualized medicine. The biobank collects blood and blood derivatives along with health information donated by Mayo Clinic patients, aiming to create a resource for studies across various health conditions, without focusing on any specific disease.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> 56,000 participants. </li>
            <li><strong>Data Types:</strong> Genomic data, electronic health records (EHRs), biospecimens such as DNA, serum, plasma, and white blood cells, and self-reported health and lifestyle information.</li>
            <li><strong>Research Areas:</strong> Personalized medicine, chronic disease research, pharmacogenomics, and various common diseases like hyperlipidemia, hypertension, osteoarthritis, and cancer.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.mayo.edu/research/centers-programs/mayo-clinic-biobank/overview" target="_blank">Mayo Clinic Biobank</a></p>
        <p><strong>Publication:</strong> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258707/" target="_blank">The Mayo Clinic Biobank: A building block for individualized medicine</a></p>
    </div>
    <div class="biobank">
        <h2>9. 1000 Genomes Project (IGSR: The International Genome Sample Resource)</h2>
        <p><strong>Introduction:</strong><br>The 1000 Genomes Project created a catalogue of common human genetic variation, using openly consented samples from people who declared themselves to be healthy. The reference data resources generated by the project remain heavily used by the biomedical science community. The International Genome Sample Resource (IGSR) maintains and shares the human genetic variation resources built by the 1000 Genomes Project. We also update the resources to the current reference assembly, add new data sets generated from the 1000 Genomes Project samples and add data from projects working with other openly consented samples.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> 2,504 individuals from 26 populations across the globe. </li>
            <li><strong>Data Types:</strong> Whole-genome sequences, exome sequences, short and structural variations, genotype imputation.</li>
            <li><strong>Research Areas:</strong> Human genetic variation, population genetics, genetic association studies, structural variation analysis.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.internationalgenome.org/" target="_blank">The International Genome Sample Resource</a></p>
        <p><strong>Publication:</strong> <a href="https://academic.oup.com/nar/article/48/D1/D941/5580898?login=false" target="_blank">The International Genome Sample Resource (IGSR) collection of open human genomic variation resources</a></p>
    </div>
    <div class="biobank">
        <h2>10. Genome Aggregation Database (gnomAD)</h2>
        <p><strong>Introduction:</strong><br>The Genome Aggregation Database (gnomAD), originally launched in 2014 as the Exome Aggregation Consortium (ExAC), is the result of a coalition of investigators willing to share aggregate exome and genome sequencing data from a variety of large-scale sequencing projects, and make summary data available for the wider scientific community. The gnomAD database is composed of exome and genome sequences from around the world. </p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> gnomAD v4 includes data from 807,162 individuals, comprising 730,947 exomes and 76,215 genomes. </li>
            <li><strong>Data Types:</strong> The dataset includes short variants such as SNVs (Single Nucleotide Variants) and InDels, as well as structural variants (SVs) like deletions, duplications, insertions, inversions, and complex variants. It also includes rare coding CNVs (Copy Number Variants) with a site frequency of less than 1%.</li>
            <li><strong>Research Areas:</strong> Human genetic variation, population genetics, allele frequency reference for severe pediatric diseases.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://gnomad.broadinstitute.org/" target="_blank">Genome Aggregation Database (gnomAD)</a></p>
        <p><strong>Publication:</strong> <a href="https://www.nature.com/articles/nature19057" target="_blank">Analysis of protein-coding genetic variation in 60,706 humans</a>, <a href="https://www.nature.com/articles/s41586-020-2308-7" target="_blank">The mutational constraint spectrum quantified from variation in 141,456 humans</a></p>
    </div>
    <div class="biobank">
        <h2>11. deCODE Genetics</h2>
        <p><strong>Introduction:</strong><br>deCODE Genetics is a global leader in the discovery of genetic risk factors for common diseases. With a robust gene discovery engine that utilizes detailed genetic and medical information from around 500,000 individuals worldwide, deCODE employs proprietary statistical algorithms and informatics tools to analyze and interpret large datasets. Founded in 1996, deCODE's unique population-based approach, particularly in Iceland, has positioned the company at the forefront of gene discovery and whole-genome sequencing.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> Over 160,000 volunteer participants in Iceland, comprising more than half of the adult population, with a genealogy database covering the entire Icelandic population. </li>
            <li><strong>Data Types:</strong> Whole-genome sequences, genotypic data, genealogical records, and medical information.</li>
            <li><strong>Research Areas:</strong> Genetic risk factors for common diseases, whole-genome sequencing, gene discovery, correlation between genetic variations and phenotypes.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.decode.com/" target="_blank">deCODE Genetics</a></p>
    </div>
    <div class="biobank">
        <h2>12. 100,000 Genomes Project</h2>
        <p><strong>Introduction:</strong><br>The 100,000 Genomes Project, initiated by Genomics England, aimed to sequence 100,000 genomes from around 85,000 NHS patients who were affected by rare diseases or cancer. This British initiative has provided groundbreaking insights into the role that genomics can play in healthcare. While recruitment for the project was completed in December 2018, research and analysis continue, contributing to the advancement of genomic medicine.</p>
        <p><strong>Features:</strong></p>
        <ul>
            <li><strong>Participants:</strong> 100,000 genomes sequenced from approximately 85,000 NHS patients, focusing on those affected by rare diseases or cancer. </li>
            <li><strong>Data Types:</strong> whole genome sequences. </li>
            <li><strong>Research Areas:</strong> The project has been instrumental in advancing the diagnosis and treatment of rare diseases, cancer genomics, and the study of genetic predispositions to diseases.</li>
        </ul>
        <p><strong>Website:</strong> <a href="https://www.genomicsengland.co.uk/initiatives/100000-genomes-project" target="_blank">100,000 Genomes Project</a></p>
        <p><strong>Publication:</strong> <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2035790" target="_blank">100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report</a></p>
    </div>
</body>
</html>
